Udredning og behandling af angst og depression hos patienter med KOL

Translated title of the contribution: Examination and treatment of anxiety and depression in patients with COPD

Ida Stisen Fogh-Andersen, Ingeborg Farver-Vestergaard, Christian Møller Pedersen, Elisabeth Tehrani, Anders Løkke Ottesen*

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Abstract

An estimated 33 percent of patients with COPD have co-morbidities in terms of anxiety and/or depression (A and D). A large proportion of these patients are not diagnosed, mainly because some of the core symptoms of A and D can be misinterpreted as being caused by COPD. Untreated A and D in patients with COPD can have a negative impact on several parameters e.g. dyspnoea and mortality. On this basis, this review argues, that special focus in primary care and hospitals on diagnosing and treating A and D in patients with COPD using anti-depressants or cognitive therapy can reduce symptom burden and significantly improve quality of life.

Translated title of the contributionExamination and treatment of anxiety and depression in patients with COPD
Original languageDanish
Article numberV09200679
JournalUgeskrift for Læger
Volume183
Issue4
Number of pages9
ISSN0041-5782
Publication statusPublished - Jan 2021

Fingerprint

Dive into the research topics of 'Examination and treatment of anxiety and depression in patients with COPD'. Together they form a unique fingerprint.

Cite this